Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB Total Non-current Liabilities
All obligations due after more than one year.
Astera Labs, Inc. Common StockNASDAQ: ALAB
Total Non-current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total non-current liabilities rises 41.6% from a year ago
Total non-current liabilities stood at $41.49M at the end of Q2 FY2026, up 41.6% from a year earlier and up 3.1% from the prior quarter. Over 3 fiscal years it compounded at -48.5% a year.
Context
- Total non-current liabilities amounted to 2.1% of total assets at the end of Q2 FY2026, down 0.2 pp from a year earlier.
- Total non-current liabilities increased in 1 of the last 3 fiscal years.
What to watch
Whether total non-current liabilities keeps rising in the next quarterly balance sheet after a +41.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 35.15M USD
- Year-over-year change
- +1009.8%
- 3-year CAGR
- -48.5%
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 35.15M | +1009.8% |
| FY2024 | 2024-12-31 | 3.17M | -16.4% |
| FY2023 | 2023-12-31 | 3.79M | -98.5% |
| FY2022 | 2022-12-31 | 256.93M | — |
Total Non-current Liabilities vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's Jun 2026 total non-current liabilities of $41.49M is the lowest of the 7 companies compared; the peer median is $7.27B.
- Its year-over-year change of +41.6% is the 2nd highest of 7, against a peer median of +19.3%.
- Total non-current liabilities amounts to 2.1% of total assets for ALAB, versus a peer median of 23.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $14.64B | -4.1% | +16.3% | 39.7% | |
| Aug 2026 | $9.22B | -17.2% | -1.4% | 19.0% | |
| Jun 2026 | $8.02B | +9.0% | +11.2% | 30.8% | |
| Aug 2026 | $6.52B | +36.9% | +1.9% | 23.7% | |
| Sep 2026 | $207M | +29.5% | -2.1% | 22.6% | |
| Aug 2026 | $86.07M | +458.7% | +23.3% | 2.9% | |
| Jun 2026 | $41.49M | +41.6% | -48.5% | 2.1% | |
| Peer median (excluding ALAB) | $7.27B | +19.3% | +6.6% | 23.1% | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.